http://www.fpnotebook.com/
Gluten Enteropathy
Aka: Gluten Enteropathy, Gluten Sensitive Enteropathy, Celiac Sprue, Celiac Disease, Coeliac Disease
- Epidemiology
- Affects both adults and children
- May present as Failure to Thrive in infants
- Older patients over age 60 years represent 20% of cases
- Prevalence: 1 per 120-300 in United States and Europe (0.5 to 1%)
- More common in women (75% of adult cases)
- Family History increases risk
- Monozygotic twins: 75% concordance rate
- First degree relatives: 5-20% have Celiac Disease
- Second degree relatives: 2% have Celiac Disease
- Pathophysiology
- Small Bowel exposure to antigens in cereal grains (rye, wheat, barley)
- Immunologic disorder of Small Bowel
- Abnormal T Cell and IgA and IgG Antibody response
- Enhanced immunogenic response to a-gliadin at lamina propria
- Results in intense local inflammation at villous resulting in villous atrophy
- Significantly decreases absorptive surface
- Related to HLA Class II DQA1*0501 and DQB1*0201 (HLA-DQ2 and HLA-DQ8)
- Associated with other Autoimmune Conditions as below
- Associated conditions
- Chromosomal abnormality
- Turner's Syndrome
- Down Syndrome
- Autoimmune Conditions
- Type I Diabetes Mellitus (2-8% comorbidity)
- Autoimmune Thyroid disease (<14% comorbidity)
- Sjogren's Syndrome
- Primary biliary Cirrhosis
- Addison's Disease
- Systemic Lupus Erythematosus
- Selective IgA Deficiency
- Alopecia Areata
- Autoimmune Hepatitis
- Sarcoidosis
- Vitiligo
- Psoriasis
- Symptoms (secondary to malabsorption)
- Many cases are asymptomatic (up to 38%)
- Diarrhea (up to 85%)
- Fatigue (80%)
- Weight loss (45%)
- Abdominal Distention (33%)
- Excessive flatus or Eructation (28%)
- Large, bulky, foul smelling stools
- Signs: Age-related Presentations
- Gastrointestinal symptoms as described below
- Infants
- Failure to Thrive or Short Stature
- Developmental delay
- Malnutrition
- Older children
- Constitutional Short Stature
- Dental enamel defect
- Epilepsy
- Adults
- Osteopenia
- Lactose Intolerance
- Anemia
- Signs: General
- Anemia (50% of cases)
- Occult blood loss from Small Bowel inflammation
- Malabsorption
- Iron Deficiency Anemia (most common)
- Vitamin B12 Deficiency
- Folate Deficiency
- Other vitamin malabsorption
- Osteoporosis (Vitamin D Deficiency)
- Coagulopathy (Vitamin K Deficiency)
- Dermatitis Herpetiformis (10-20% of cases)
- Pathognomonic for Celiac Disease
- Diagnosis: Serologic testing
- Indications for testing
- Celiac Disease in first or second degree relatives
- Thyroid disease
- Type I Diabetes Mellitus
- Down Syndrome or Turner's Syndrome
- Infertility
- Other Indications for testing
- Irritable Bowel Syndrome
- Iron Deficiency Anemia
- Chronic Diarrhea
- Chronic Fatigue
- Unintentional Weight Loss
- Short Stature
- Osteoporosis
- Liver Function Test abnormalities (AST or ALT)
- Antibody testing
- Anti-tissue transglutaminase Antibody (TTG)
- Most sensitive test for Celiac Sprue
- May be combined with EMA
- Test Sensitivity: 95%
- Test Specificity: 90%
- Obtain IgG and IgA levels (If IgA tested only, check total IgA)
- IgA anti-endomysial Antibody (EMA)
- Test Sensitivity: >85
- Test Specificity: >96
- False negative in IgA deficient, age under 3 years
- May be used in combination with TTG
- Gliadin antibodies (not recommended, low sensitivity)
- IgA anti-gliadin Antibody
- Test Sensitivity: >53
- Test Specificity: >65
- IgG anti-gliadin Antibody
- Test Sensitivity: >57
- Test Specificity: >42
- Protocol
- Start with TTG with a reflex if positive to EMA
- Initial: Anti-tissue transglutaminase Antibody (TTG)
- Reflex: IgA anti-endomysial Antibody (EMA) if TTG is positive
- Interpretation
- All tests negative: Celiac Sprue is unlikely
- Test Sensitivity is dependent on mucosal inflammation
- Risk of false negative tests in subclinical disease and in IgA deficiency
- One or both of IgA tests positive
- Highly suggestive of Celiac Sprue
- Correlates with extensive villous atrophy
- Confirm with Small Bowel biopsy (due to false positives)
- IgG positive with IgA negative
- Obtain total quantitative IgA
- Consult with Gastroenterology to consider:
- IgA deficient: Endoscopy with biopsy
- IgA normal: Gluten challenge and endoscopy
- References
- Lewis (2006) Aliment Pharmacol Ther 24:47-54
- Diagnosis: Endoscopy with Small Bowel biopsy
- Indications
- IgA deficiency (serology unreliable)
- Confirmation of Celiac Sprue diagnosis
- High level of suspicion yet negative serologic testing
- Endoscopic biopsy of distal duodenum (gold standard)
- Villous atrophy with reactive crypt hyperplasia
- Four tissue samples are recommended to reduce false negative rate
- Differential Diagnosis
- Anorexia Nervosa
- Inflammatory Bowel Disease (e.g. Crohn's Disease)
- Intestinal infection (e.g. Giardiasis, Clostridium difficile, Tropical Sprue)
- Malabsorption (e.g. Lactose Intolerance)
- Mesenteric Ischemia
- Tuberculosis
- Intestinal Lymphoma
- Immunodeficiency (e.g. Human Immunodeficiency Virus, Hypogammaglobulinemia)
- Whipple's Disease
- Zollinger-Ellison Syndrome
- Irritable Bowel Syndrome
- Initial misdiagnosis in 36% of patients ultimately diagnosed with Celiac Disease
- Labs: Initial at time of initial diagnosis
- Complete Blood Count with platelets
- Iron studies (Serum Iron, TIBC, Ferritin)
- Serum Vitamin B12
- Serum Folate
- Calcium
- Phosphate
- Renal Function tests (Blood Urea Nitrogen, Creatinine)
- Liver Function Tests (AST, ALT, Albumin, Alk Phos)
- Imaging (at time of diagnosis and as warranted)
- DEXA Scan of spine and hips
- Management
- Strict Gluten-Free Diet
- Consider monitoring with serologic markers (TTG or EMA as described above)
- Should return to normal within 3-12 months of starting Gluten-Free Diet
- Persistent positive markers suggests continue gluten exposure
- Complications
- Osteoporosis (from calcium and Vitamin D malabsorption)
- Neurologic disorders
- Cerebral calcifications
- Ataxia
- Peripheral Neuropathy
- Seizure disorder
- Untreated or refractory Celiac Sprue complications
- Intestinal stricture (and Bowel Obstruction)
- Non-Hodgkin's Lymphoma (relative risk: 3 to 6)
- Small intestinal cancers (relative risk: 10)
- T-Cell Lymphoma
- Cryptic Lymphoma should be considered if refractory
- Oropharyngeal cancers (relative risk: 2.3)
- Esophageal Cancers (relative risk: 4.2)
- Right-sided bowel adenocarcinoma (relative risk: 2.3)
- Primary liver cancer (relative risk: 2.7)
- Course: Following gluten free diet started
- Clinical improvement in several days
- Restoration of normal histology in weeks to months
- Diarrhea recurrence despite Gluten-Free Diet causes
- Gluten returned to diet (most common)
- Lactose Intolerance
- Microscopic Colitis
- Pancreatic insufficiency
- Irritable Bowel Syndrome
- Refractory Celiac Sprue
- Small intestinal cancer (T-Cell Lymphoma)
- Resources
- Celiac Sprue Association
- http://www.csaceliacs.org
- PO Box 31700 Omaha, Nebraska 68131,Tel: 402/558-0600
- Celiac Disease and Gluten-Free Diet Support Page
- http://www.celiac.com
- Celiac Disease Foundation
- http://www.celiac.org
- Celiac Disease resources for providers
- http://www.uams.edu/celiac
- References
- Ciclitira (2001) Gastroenterology 120:1526-40
- Dewar (2005) Gastroenterology 128: S19-S24
- Farrell (2002) N Engl J Med 346:180-8
- Nelsen (2002) Am Fam Physician 66(12):2259-66
- Presutti (2007) Am Fam Physician 76(12): 1795-1810
- Treem (2004) Curr Opin Pediatr 16:552-559